Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.42K Hold
80
﹤0.01% 206
2025
Q4
$3.92K Hold
80
﹤0.01% 221
2025
Q3
$3.45K Hold
80
﹤0.01% 211
2025
Q2
$3.07K Hold
80
﹤0.01% 213
2025
Q1
$3.1K Buy
+80
New +$2.93K ﹤0.01% 212
2019
Q4
$5K Hold
80
﹤0.01% 253
2019
Q3
$4K Buy
+80
New +$4.12K ﹤0.01% 231
2019
Q1
$4K Hold
80
﹤0.01% 212
2018
Q4
$4K Buy
+80
New +$3.94K ﹤0.01% 209

Other funds holding GSK

1 North Wealth Services's GSK Position: Q1 2026 in Review

1 North Wealth Services held its GSK (GSK) position steady in Q1 2026 at 80 shares worth $4.42K. The position accounts for ﹤0.01% of the portfolio, ranked #206.

1 North Wealth Services first reported a position in GSK in Q4 2018 and has held it in 9 quarters since. The position peaked at $5K in Q4 2019. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • 1 North Wealth Services held 80 shares of GSK worth $4.42K as of Q1 2026.
  • 1 North Wealth Services left its GSK share count unchanged in Q1 2026.
  • GSK made up ﹤0.01% of 1 North Wealth Services's portfolio in Q1 2026, its #206 holding.
  • 1 North Wealth Services first reported a position in GSK in Q4 2018 and has held it in 9 quarters since.
  • 1 North Wealth Services's GSK position peaked at $5K in Q4 2019.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on 1 North Wealth Services's 13F filing for Q1 2026, filed 4 May 2026.